The Korean Journal of Food And Nutrition (한국식품영양학회지)

The Korean Society of Food and Nutrition (한국식품영양학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Lactobacillus helveticus HY7801 Oral Administration on Immune Response and Skin Improvement in Animal Model of Atopic Dermatitis

유산균제제(Lactobacillus helveticus HY7801)의 경구 투여가 아토피 피부염 동물모델의 면역 반응 및 피부 개선에 미치는 효과

  • Received : 2020.01.23
  • Accepted : 2020.04.07
  • Published : 2020.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Probiotics improve the immune system. However, the effects of its lactic acid bacteria on atopic dermatitis relief and inflammation improvement is not fully understood. Recently, one of the probiotics, Lactobacillus helveticus HY7801 (HY7801), was found to have an anti-inflammatory effect. In this study, we investigated the effects of HY7801 on atopic dermatitis-induced animal models. After four weeks of oral administration, the group treated with HY7801 showed amelioration of the atopic dermatitis compared to the group receiving placebo. In the HY7801 treated group, the epidermal hyper-proliferation and collagen deposition were inhibited compared to the placebo group, and the secretion amount of the inflammatory factors, such as TNF-α, IL-4 were reduced. In conclusion, these results suggest that HY7801 acts as a functional probiotic via amelioration of the atopic dermatitis such as a decrease of epidermal hyper-proliferation, and collagen deposition and anti-inflammatory effects.

Keywords

References

  1. Biedermann T, Skabytska Y, Kaesler S, Volz T. 2015. Regulation of T cell immunity in atopic dermatitis by microbes: The Yin and Yang of cutaneous inflammation. Front Immunol 6:353
  2. Brandt EB, Sivaprasad U. 2011. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol 2:110
  3. Danso MO, van Drongelen V, Mulder A, van Esch J, Scott H, van Smeden J, El Ghalbzouri A, Bouwstra JA. 2014. $TNF-{\alpha}$ and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and Stratum corneum lipids in human skin equivalents. J Invest Dermatol 134:1941-1950 https://doi.org/10.1038/jid.2014.83
  4. Ding YH, Qian LY, Pang J, Lin JY, Xu Q, Wang LH, Huang DS, Zou H. 2017. The regulation of immune cells by Lactobacilli: A potential therapeutic target for antiatherosclerosis therapy. Oncotarget 8:59915-59928 https://doi.org/10.18632/oncotarget.18346
  5. Foster AP, Knowles TG, Moore AH, Cousins PD, Day MJ, Hall EJ. 2003. Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease. Vet Immunol Immunopathol 92:113-124 https://doi.org/10.1016/S0165-2427(03)00033-3
  6. Greenhawt M. 2010. The role of food allergy in atopic dermatitis. Allergy Asthma Proc 31:392-397 https://doi.org/10.2500/aap.2010.31.3393
  7. Hammerberg B. 2009. Canine immunoglobulin E. Vet Immunol Immunopathol 132:7-12 https://doi.org/10.1016/j.vetimm.2009.09.009
  8. Hill DJ, Sporik R, Thorburn J, Hosking CS. 2000. The association of atopic dermatitis in infancy with immunoglobulin E food sensitization. J Pediatr 137:475-479 https://doi.org/10.1067/mpd.2000.108207
  9. Jang HY, Koo JH, Lee SM, Park BH. 2018. Atopic dermatitislike skin lesions are suppressed in fat-1 transgenic mice through the inhibition of inflammasomes. Exp Mol Med 50:1-9
  10. Joo HM, Kim KA, Myoung KS, Ahn YT, Lee JH, Huh CS, Han MJ, Kim DH. 2012. Lactobacillus helveticus HY7801 ameliorates vulvovaginal candidiasis in mice by inhibiting fungal growth and NF-kB activation. Int Immunopharmacol 14:39-46 https://doi.org/10.1016/j.intimp.2012.05.023
  11. Kang SA, Choi HJ, Kim JH. 2012. Development and application of nutrition education program for prevention and management of atopic dermatitis. Korean J Food Nutr 25:383-392 https://doi.org/10.9799/ksfan.2012.25.2.383
  12. Kanoh H, Ishitsuka A, Fujine E, Matsuhaba S, Nakamura M, Ito H, Inagaki N, Banno Y, Seishima M. 2019. IFN-${\gamma}$ reduces epidermal barrier function by affecting fatty acid composition of ceramide in a mouse atopic dermatitis model. J Immunol Res 2019:3030268 https://doi.org/10.1155/2019/3030268
  13. Kawahara T, Hanzawa N, Sugiyama M. 2018. Effect of Lactobacillus strains on thymus and chemokine expression in keratinocytes and development of atopic dermatitislike symptoms. Benefic Microbes 9:643-652 https://doi.org/10.3920/BM2017.0162
  14. Kim EY, Jo KG, Ahn SH, Park SS, Son HS, Han SH. 2015a. Effect of lactic acid bacteria powder on loperamideinduced constipation in rat. Korean J Food Nutr 28:956-964 https://doi.org/10.9799/ksfan.2015.28.6.956
  15. Kim JE, Chae CS, Kim GC, Hwang W, Hwang JS, Hwang SM, Kim Y, Ahn YT, Park SG, Jun CD, Rudra D, Im SH. 2015b. Lactobacillus helveticus suppresses experimental rheumatoid arthritis by reducing inflammatory T cell responses. J Funct Foods 13:350-362 https://doi.org/10.1016/j.jff.2015.01.002
  16. Ku JM, Hong SH, Kim SR, Choi HS, Kim HI, Kim DU, Oh SM, Seo HS, Kim TY, Shin YC, Cheon C, Ko SG. 2018. The prevention of 2,4-dinitrochlorobenzene-induced inflammation in atopic dermatitis-like skin lesions in BALB/c mice by Jawoongo. BMC Complement Altern Med 18:215 https://doi.org/10.1186/s12906-018-2280-z
  17. Lee JH, Hong SW, Kim SA, Choi HJ, Kim MK, Suh YS. 2016. Beneficial effect of diet intervention on school children with atopic dermatitis. Korean J Health Promot 16:32-36 https://doi.org/10.15384/kjhp.2016.16.1.32
  18. Lee SI, Kim J, Han Y, Ahn K. 2011. A proposal: Atopic Dermatitis Organizer (ADO) guideline for children. Asia Pac Allergy 1:53-63 https://doi.org/10.5415/apallergy.2011.1.2.53
  19. Li T, Gu M, Liu P, Liu Y, Guo J, Zhang W, Qian C, Deng A. 2018. Clinical significance of decreased interleukin-35 expression in patients with psoriasis. Microbiol Immunol 62:454-461 https://doi.org/10.1111/1348-0421.12605
  20. Marsella R, Ahrens K, Sanford R. 2018. Investigation of the correlation of serum IL-31 with severity of dermatitis in an experimental model of canine atopic dermatitis using beagle dogs. Vet Dermatol 29:69-e28 https://doi.org/10.1111/vde.12500
  21. Martel BC, Lovato P, Baumer W, Olivry T. 2017. Translational animal models of atopic dermatitis for preclinical studies. Yale J Biol Med 90:389-402
  22. Murray C, Ahrens K, Devalaraja M, Dymond M, Fagura M, Hargreaves A, Holt A, Peers I, Price S, Reens J, Riley R, Marsella R. 2016. Use of a canine model of atopic dermatitis to investigate the efficacy of a CCR4 antagonist in allergen-induced skin inflammation in a randomized study. J Invest Dermatol 136:665-671 https://doi.org/10.1016/j.jid.2015.11.001
  23. Olivry T, Marsella R, Iwasaki T, Mueller R. 2007. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis. Vet Dermatol 18:78-86 https://doi.org/10.1111/j.1365-3164.2007.00569.x
  24. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF. 2007. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. J Lipid Res 48:751-762 https://doi.org/10.1194/jlr.R600021-JLR200
  25. Raap U, Weissmantel S, Gehring M, Eisenberg AM, Kapp A, Folster-Holst R. 2012. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol 23:285-288 https://doi.org/10.1111/j.1399-3038.2011.01241.x
  26. Ryu DH, Oh SR, Jung TS, Ryu DS. 2017. The effect of Angelica gigas Nakai extract and Bacillus polyfermenticus KJS-2 on atopic dermatitis induced by DNCB in mice. J Korean Med 38:30-42 https://doi.org/10.13048/jkm.17023
  27. Sehgal VN, Khurana A, Mendiratta V, Saxena D, Srivastava G, Aggarwal AK. 2015. Atopic dermatitis; etio-pathogenesis, An overview. Indian J Dermatol 60:327-331 https://doi.org/10.4103/0019-5154.160474
  28. Shin JH, Chung MJ, Seo JG. 2016. A multistrain probiotic formulation attenuates skin symptoms of atopic dermatitis in a mouse model through the generation of $CD4^{+}Foxp3^{+}$ T cells. Food Nutr Res 60:32550 https://doi.org/10.3402/fnr.v60.32550
  29. Song DU, Min GY, Hong SY, Lim SE, Huh J, Sohn YH, Jung HS. 2019. Effects of KMS on the DNCB induced animal model of atopic dermartitis. J Korean Med 40:63-77
  30. Tarpataki N, Thuroczy J, Fischer N, Jacquenet S, Rostaher A, Richard C, Zwickl L, Olivry T, Favrot C. 2018. A pilot study of total and allergen-specific IgE serum levels during anestrous, estrous and pregnancy in healthy female dogs. Vet Dermatol 29:329-e115 https://doi.org/10.1111/vde.12544
  31. Werfel T, Allam JP, Biedermann T, Eyerich K, Gilles S, Guttman-Yassky E, Hoetzenecker W, Knol E, Simon HU, Wollenberg A, Bieber T, Lauener R, Schmid-Grendelmeier P, Traidl-Hoffmann C, Akdis CA. 2016. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol 138:336-349 https://doi.org/10.1016/j.jaci.2016.06.010
  32. Wong LS, Wu T, Lee CH. 2017. Inflammatory and noninflammatory itch: Implications in pathophysiology-directed treatments. Int J Mol Sci 18:E1485
  33. Yoon JA, Shin KO. 2017. Studies on the function of lactic acid bacteria and related yeasts in probiotics: A review. Korean J Food Nutr 30:395-404 https://doi.org/10.9799/ksfan.2017.30.3.395
  34. Yoshizawa Y, Nomaguchi H, Izaki S, Kitamura K. 2002. Serum cytokine levels in atopic dermatitis. Clin Exp Dermatol 27:225-229 https://doi.org/10.1046/j.1365-2230.2002.00987.x